2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose

CAS : 68567-47-5

Ref. 3D-MB167649

Informations sur le produit

• Nom: 2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose
• Marque: Biosynth
• Description: 2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose (BTDG) is a nitro derivative of L-threonine that has been derivatized with an acetyl group and a molecule of 2,4,6-trideoxygalactose. BTDG has been shown to be safe in clinical trials for vaccine development against life-threatening diseases. It is the first glycopolymer approved by the FDA for clinical use in humans. This drug has been shown to increase the antibody response and improve protection against influenza virus infection. BTDG also inhibits bacterial replication by blocking protein synthesis in some bacteria and inhibiting glycolysis in others.

Propriétés chimiques

• Masse moléculaire: 246.26 g/mol
• Formule: C₁₀H₁₈N₂O₅
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder